Tango Therapeutics, Inc.: Wedbush cuts target price to $40 from $45
TNGX•Wedbush cut its target price for Tango Therapeutics to $40 from $45.
Related News
CVR Energy to buy St. Paul Park, Mandan refineries for $4.2 billion
CVI•
Owlting Group secures additional US$5 million financing from The Lind Partners
OWLS•
Obook Holdings signs $5 million financing agreement with Lind Global Asset Management XV
OWLS•
California Resources CEO Francisco Leon reports $37,307.84 share purchase
CRC•
Nasdaq trade halt reason not available at 9:00 a.m.
UCFI•